SCHEMBL4419586

SCHEMBL4419586

OC1[C@H](O)COC[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20234345 1.00
SCHEMBL12816981 1.00
SCHEMBL26220759 1.00
SCHEMBL2614515 1.00
SCHEMBL2622546 1.00
SCHEMBL3717111 1.00
SCHEMBL30975 1.00
SCHEMBL17028487 1.00
Water SCHEMBL28199872 0.96 FUCA1 (0.35)
Hydrogen Sulfide SCHEMBL27937063 0.96 FUCA1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250134147-A1 METHODS AND COMPOSITIONS FOR IMPROVED SUGAR-LIKE TASTE ALMENDRA THAILAND LTD (TH) 2025-05-01 US disclosed
EP-4466278-A1 SAPONIN-BASED ADJUVANTS AND VACCINES Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE (ES) 2024-11-27 EP disclosed
US-20240324640-A1 METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY ALMENDRA PTE LTD (SG) 2024-10-03 US disclosed
US-20240074461-A1 METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY ALMENDRA PTE LTD (SG) 2024-03-07 US disclosed
US-20240041078-A1 METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY ALMENDRA PTE LTD (SG) 2024-02-08 US disclosed
US-11827664-B2 Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway REATA PHARMACEUTICALS, INC (US) 2023-11-28 US disclosed
WO-2023167238-A1 METHOD FOR PRODUCING Fc-CONTAINING MOLECULE 第一三共株式会社 2023-09-07 WO disclosed
WO-2023139145-A1 SAPONIN-BASED ADJUVANTS AND VACCINES ASOCIACIÓN CENTRO DE INVESTIGACIÓN COOPERATIVA EN BIOCIENCIAS-CIC BIOGUNE (ES) 2023-07-27 WO disclosed
CN-113773291-B Improved synthesis method of glass color factor of cosmetic active ingredient 上海昕凯医药科技有限公司 2023-04-25 CN disclosed
US-20220264924-A1 METHODS AND COMPOSITIONS FOR IMPROVED TASTE QUALITY ALMENDRA PTE. LTD. (SG) 2022-08-25 US disclosed
EP-3377507-B1 NEW 5-AZIDO-5-DEOXY-2:3-ISOPROPYLIDENE-D-ARABINOSE COMPOUNDS; THEIR METHOD OF MANUFACTURE AND THEIR USE FOR THE SYNTHESIS OF ARA-N3, KDO-N3 AND 4EKDO-N3 CENTRE NAT RECH SCIENT (FR) 2021-12-08 EP disclosed
EP-3558394-B1 TETRAAZABICYCLO-MACROCYCLE BASED MANGANESE CHELATE COMPOUNDS SUITABLE AS MRI IMAGING AGENTS GE HEALTHCARE AS (NO) 2020-06-03 EP disclosed
EP-3170830-A1 NEW 5-AZIDO-5-DEOXY-2 :3-ISOPROPYLIDENE-D-ARABINOSE COMPOUNDS ; THEIR METHOD OF MANUFACTURE AND THEIR USE FOR THE SYNTHESIS OF ARA-N3, KDO-N3 AND 4EKDO-N3 Centre National De La Recherche Scientifique (FR) 2017-05-24 EP disclosed
US-7528153-B2 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors GENZYME CORPORATION (US) 2009-05-05 US disclosed
US-20070066581-A1 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors GENZYME CORPORATION 2007-03-22 US disclosed
WO-2007009772-A1 THIOCOLCHICOSIDE ANALOGUES WITH MYORELAXANT AND ANTI-INFLAMMATORY ACTIVITY INDENA S.P.A. (IT) 2007-01-25 WO disclosed
EP-1680403-A1 DEOXYNOJIRIMYCIN ANALOGUES AND THEIR USES AS GLUCOSYLCERAMIDASE INHIBITORS MacroZyme B.V. (NL) 2006-07-19 EP disclosed
WO-2005040118-A1 DEOXYNOJIRIMYCIN ANALOGUES AND THEIR USES AS GLUCOSYLCERAMIDASE INHIBITORS MACROZYME B.V. (NL) 2005-05-06 WO disclosed
EP-1528056-A1 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors Academisch Ziekenhuis bij de Universiteit van Amsterdam (NL) 2005-05-04 EP disclosed
US-5654280-A Pharmaceutical composition PERSTORP AB (SE) 1997-08-05 US disclosed